Valeant Pharma Reports EPS of $0.62 vs. $0.58 a Year Ago Revenues $565M vs. $297.1M Estimate (VRX)

by Benzinga Staff
May 9, 2011 8:04 AM | 7 seconds read |
Valeant Pharma VRX Reports EPS of $0.62 vs. $0.58 a Year Ago Revenues $565M vs. $297.1M Estimate
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: EarningsNewsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!